Design Therapeutics, Inc. (DSGN) stock
DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.84−0.08 (-0.81%)
Close on Nov 17, 2026Market cap $615.80MP/E –Yield –
Design Therapeutics cash
Cash and short-term investments held at the end of each period.
Design Therapeutics's cash was $207.40M at Jun 30, 2026. For fiscal 2025 it was $219.80M, down 10.5% from the year before. The highest annual figure on record is $384.10M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $219.80M | -10.5% |
| FY2024 | Dec 31, 2024 | $245.50M | -12.9% |
| FY2023 | Dec 31, 2023 | $281.80M | -14.7% |
| FY2022 | Dec 31, 2022 | $330.40M | -14.0% |
| FY2021 | Dec 31, 2021 | $384.10M | +964.3% |
| FY2020 | Dec 31, 2020 | $36.09M | +46771.4% |
| FY2019 | Dec 31, 2019 | $77.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $207.40M | -4.1% |
| Q1 FY2026 | Mar 31, 2026 | $222.80M | -3.0% |
| Q4 FY2025 | Dec 31, 2025 | $219.80M | -10.5% |
| Q3 FY2025 | Sep 30, 2025 | $206.00M | -18.9% |
| Q2 FY2025 | Jun 30, 2025 | $216.30M | -17.1% |
| Q1 FY2025 | Mar 31, 2025 | $229.70M | -15.1% |
| Q4 FY2024 | Dec 31, 2024 | $245.50M | -12.9% |
| Q3 FY2024 | Sep 30, 2024 | $254.10M | -12.7% |
| Q2 FY2024 | Jun 30, 2024 | $261.00M | -13.9% |
| Q1 FY2024 | Mar 31, 2024 | $270.70M | -14.2% |
| Q4 FY2023 | Dec 31, 2023 | $281.80M | -14.7% |
| Q3 FY2023 | Sep 30, 2023 | $290.90M | -15.5% |
| Q2 FY2023 | Jun 30, 2023 | $303.10M | -15.7% |
| Q1 FY2023 | Mar 31, 2023 | $315.40M | -15.0% |
| Q4 FY2022 | Dec 31, 2022 | $330.40M | -14.0% |
| Q3 FY2022 | Sep 30, 2022 | $344.20M | -12.6% |
| Q2 FY2022 | Jun 30, 2022 | $359.40M | -10.8% |
| Q1 FY2022 | Mar 31, 2022 | $371.20M | -9.8% |
| Q4 FY2021 | Dec 31, 2021 | $384.10M | +964.3% |
| Q3 FY2021 | Sep 30, 2021 | $393.72M | +12112.1% |
| Q2 FY2021 | Jun 30, 2021 | $402.84M | +21146.6% |
| Q1 FY2021 | Mar 31, 2021 | $411.34M | +15123.5% |
| Q4 FY2020 | Dec 31, 2020 | $36.09M | +46771.4% |
| Q3 FY2020 | Sep 30, 2020 | $3.22M | – |
| Q2 FY2020 | Jun 30, 2020 | $1.90M | – |
| Q1 FY2020 | Mar 31, 2020 | $2.70M | – |
| Q4 FY2019 | Dec 31, 2019 | $77.00K | – |
See a number that looks wrong?